# FDA 483 - Vemulkonda Koneti Rao, M.D. - October 29, 2025

Source: https://www.keypedia.com/records/483/vemulkonda-koneti-rao-md/db0356a3-4cbe-4992-9aa8-78e33abbbfbb

> FDA 483 for Vemulkonda Koneti Rao, M.D. on October 29, 2025. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Vemulkonda Koneti Rao, M.D.
- Inspection Date: 2025-10-29
- Product Type: drugs
- Office Name: Baltimore District Office
- Summary: Vemulkonda K. Rao, M.D., a clinical investigator in Bethesda, MD, was cited for significant deviations from their investigational plan during an FDA inspection. The inspection revealed failures to report adverse events and conduct proper assessments for all five study subjects, as well as inaccurate reporting of concomitant medications for two subjects. These findings indicate a serious lack of adherence to clinical trial protocols.

## Related Documents

- [483 - 2022-10-07](https://www.keypedia.com/records/483/vemulkonda-koneti-rao-md/58c62d33-f9c8-4096-8a74-ebb0cc54c3ec)

## Related Officers

- [Consumer Safety Officer/BIMO Investigator](https://www.keypedia.com/people/david-l-chon/227b9c21-14c4-442b-bdc3-ad167567fd92)
- [Lucilla Facchin](https://www.keypedia.com/people/lucilla-facchin/e5c5c863-b2f4-44a8-8093-d1cb4f71949b)

Company: https://www.keypedia.com/companies/vemulkonda-koneti-rao-md/1077f51d-4271-4061-bde8-34e77e0e820a

Office: https://www.keypedia.com/offices/baltimore-district-office/6be371ff-03e9-4039-999c-ff170f17a9fa